Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 17, 2016British Journal of Haematology

Single versus tandem high‐dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long‐term results from the phase III GMMG‐HD2 trial

View Full Paper
Ask AI
Bookmark
Share

Authors

KEK. EliasABAxel BennerUBUta Bertsch

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Elias et al. (2016) studied this question.

synapsesocial.com/papers/6a1014e62badbc352aff4884https://doi.org/10.1111/bjh.13994
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long‐term outcome results of the first tandem autotransplant trial for multiple myeloma2006 · 163 citations
  2. 2Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma2004 · 817 citations
  3. 3A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival1975 · 3,057 citations
  4. 4Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial2012 · 832 citations
  5. 5Tandem Versus Single Autologous Hematopoietic Cell Transplantation for the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis2009 · 101 citations